PF
ABBV icon

Phoenix Financial’s AbbVie ABBV Stock Holding History

Phoenix Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
47,441
+11,150
+31% +$2.4M 0.08% 89
2026
Q1 		$7.93M Sell
36,291
-2,561
-7% -$568K 0.08% 95
2025
Q4 		$8.88M Buy
38,852
+8,047
+26% +$1.83M 0.1% 88
2025
Q3 		$7.13M Buy
30,805
+3,069
+11% +$625K 0.09% 102
2025
Q2 		$5.15M Buy
27,736
+2,152
+8% +$400K 0.07% 130
2025
Q1 		$5.37M Buy
25,584
+2,976
+13% +$579K 0.08% 121
2024
Q4 		$4.02M Sell
22,608
-6,346
-22% -$1.17M 0.05% 152
2024
Q3 		$5.73M Buy
28,954
+21,013
+265% +$3.92M 0.08% 127
2024
Q2 		$1.35M Sell
7,941
-19,839
-71% -$3.29M 0.02% 202
2024
Q1 		$5.06M Buy
+27,780
New +$4.79M 0.07% 136
2023
Q3 		– Sell
-9,663
Closed -$1.31M – 323
2023
Q2 		$1.31M Sell
9,663
-1,605
-14% -$235K 0.03% 196
2023
Q1 		$1.81M Buy
11,268
+3,017
+37% +$461K 0.04% 153
2022
Q4 		$1.35M Sell
8,251
-6,650
-45% -$1.02M 0.03% 158
2022
Q3 		$2.13M Buy
14,901
+1,552
+12% +$223K 0.05% 141
2022
Q2 		$2.04M Sell
13,349
-138
-1% -$21.1K 0.04% 165
2022
Q1 		$2.19M Sell
13,487
-131,502
-91% -$19.1M 0.04% 184
2021
Q4 		$19.6M Sell
144,989
-151,000
-51% -$17.8M 0.32% 79
2021
Q3 		$31.9M Sell
295,989
-24,137
-8% -$2.76M 0.55% 62
2021
Q2 		$36.1M Sell
320,126
-47,212
-13% -$5.32M 0.69% 57
2021
Q1 		$39.8M Buy
367,338
+277,338
+308% +$29.7M 0.9% 36
2020
Q4 		$9.63M Buy
+90,000
New +$8.65M 0.26% 109
2020
Q3 		– Sell
-21,436
Closed -$2M – 318
2020
Q2 		$2M Buy
+21,436
New +$1.89M 0.08% 159

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Phoenix Financial's ABBV Position: Q2 2026 in Review

Phoenix Financial increased its AbbVie (ABBV) stake by 31% in Q2 2026, buying an estimated $2.4M and bringing the position to 47,441 shares worth $12M. The position accounts for 0.08% of the portfolio, ranked #89.

Phoenix Financial first reported a position in ABBV in Q2 2020 and has held it in 22 quarters since. The position peaked at $39.8M in Q1 2021. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Phoenix Financial held 47,441 shares of AbbVie worth $12M as of Q2 2026.
  • Phoenix Financial bought 11,150 AbbVie shares in Q2 2026, an estimated $2.4M.
  • AbbVie made up 0.08% of Phoenix Financial's portfolio in Q2 2026, its #89 holding.
  • Phoenix Financial first reported a position in AbbVie in Q2 2020 and has held it in 22 quarters since.
  • Phoenix Financial's AbbVie position peaked at $39.8M in Q1 2021.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.